Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
918.50 DKK | +0.47% | +4.20% | +31.57% |
13/09 | Eli Lilly invests $1.8 billion in Ireland sites to scale up Alzheimer's, obesity drug production | RE |
12/09 | NOVO NORDISK : Deutsche Bank keeps its Buy rating | ZD |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
NOVO NORDISK A/S | Other Pharmaceuticals | +0.47% | +4.20% | +31.57% | +34.50% | +445.67% | 605B |
Technical Rankings Surperformance
- Stock Market
- Equities
- NOVO B Stock
- Charts Novo Nordisk A/S
- Comparison Chart
MarketScreener is also available in this country: United States.
Switch edition